ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
ResMed (RMD) Tops Q3 EPS by 4c, Revenues Beat
May 2, 2019 4:24 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $0.89, $0.04 better than the analyst estimate of $0.85. Revenue for the quarter came in at $662.2 million versus the consensus estimate of $657.77 million.
Revenue increased 12% to $662.2 million; up 15% on a constant currency basisGross margin expanded 100bps to... More